Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results

Kinnate Biopharma Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/05/2023 4 Williams Richard Thomas (Chief Medical Officer) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Paid exercise price by delivering 541 shares @ $4.3, valued at $2.3k
06/05/2023 4 Meltz Mark A (COO General Counsel Secretary) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Paid exercise price by delivering 541 shares @ $4.3, valued at $2.3k
06/05/2023 4 Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Paid exercise price by delivering 1,459 shares @ $4.3, valued at $6.3k
05/10/2023 4 Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 1,550,956 shares @ $2.8, valued at $4.3M
Bought 229,044 shares @ $2.8, valued at $641.3k
05/10/2023 4 Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 1,550,956 shares @ $2.8, valued at $4.3M
Bought 229,044 shares @ $2.8, valued at $641.3k
05/08/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 312,991 shares @ $2.75, valued at $860.7k
Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 490,512 shares @ $2.82, valued at $1.4M
Bought 490,511 shares @ $2.82, valued at $1.4M
05/08/2023 4 GORDON CARL L (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 312,991 shares @ $2.75, valued at $860.7k
Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 490,512 shares @ $2.82, valued at $1.4M
Bought 490,511 shares @ $2.82, valued at $1.4M
05/02/2023 4 GORDON CARL L (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 60,998 shares @ $2.55, valued at $155.5k
Bought 228,754 shares @ $2.55, valued at $583.3k
Bought 60,997 shares @ $2.55, valued at $155.5k
Bought 124,544 shares @ $2.62, valued at $326.3k
Bought 467,068 shares @ $2.62, valued at $1.2M
Bought 124,545 shares @ $2.62, valued at $326.3k
Bought 58,826 shares @ $2.67, valued at $157.1k
Bought 220,610 shares @ $2.67, valued at $589k
Bought 58,826 shares @ $2.67, valued at $157.1k
05/02/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 60,998 shares @ $2.55, valued at $155.5k
Bought 228,754 shares @ $2.55, valued at $583.3k
Bought 60,997 shares @ $2.55, valued at $155.5k
Bought 124,544 shares @ $2.62, valued at $326.3k
Bought 467,068 shares @ $2.62, valued at $1.2M
Bought 124,545 shares @ $2.62, valued at $326.3k
Bought 58,826 shares @ $2.67, valued at $157.1k
Bought 220,610 shares @ $2.67, valued at $589k
Bought 58,826 shares @ $2.67, valued at $157.1k
02/23/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 550,000 shares @ $0
Granted 550,000 shares @ $0
02/23/2023 3 OrbiMed Capital GP VIII LLC (10% Owner) has filed a Form 3 on Kinnate Biopharma Inc.
02/22/2023 4 GORDON CARL L (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 550,000 shares @ $0
Granted 550,000 shares @ $0
02/22/2023 4 Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Acquired 1,100,000 shares @ $0
02/22/2023 4 Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Acquired 1,100,000 shares @ $0
02/14/2023 4 Meltz Mark A (COO General Counsel Secretary) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 215,000 options to buy @ $6.78, valued at $1.5M
02/14/2023 4 Williams Richard Thomas (Chief Medical Officer) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 215,000 options to buy @ $6.78, valued at $1.5M
02/14/2023 4 Farzan Nima (CEO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 750,000 options to buy @ $6.78, valued at $5.1M
02/14/2023 4 Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 215,000 options to buy @ $6.78, valued at $1.5M
12/02/2022 4 Williams Richard Thomas (Chief Medical Officer) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Paid exercise price by delivering 541 shares @ $7.75, valued at $4.2k
12/02/2022 4 Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Paid exercise price by delivering 1,459 shares @ $7.75, valued at $11.3k
12/02/2022 4 Meltz Mark A (COO General Counsel Secretary) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Paid exercise price by delivering 541 shares @ $7.75, valued at $4.2k
09/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2022 4 Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 67,500 shares @ $0
09/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2022 4 Williams Richard Thomas (Chief Medical Officer) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 15,000 shares @ $8.64, valued at $129.6k
Bought 25,000 shares @ $8.37, valued at $209.3k
02/15/2022 4 GORDON CARL L (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 156,000 shares @ $10.22, valued at $1.6M
Bought 20,700 shares @ $9.98, valued at $206.6k
Bought 10,000 shares @ $9.89, valued at $98.9k
Bought 9,000 shares @ $9.96, valued at $89.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy